Are CHD Chemicals Ltd latest results good or bad?

CHD Chemicals Ltd's latest financial results for Q4 FY26 reveal a complex picture of operational challenges and modest revenue growth. The company reported net sales of ₹1.53 crores, reflecting a 15.91% sequential improvement from the previous quarter and a 6.25% increase year-on-year. However, despite this revenue growth, the company continued to experience net losses, with a reported loss of ₹0.02 crores, although this was an improvement from a loss of ₹0.05 crores in the prior quarter. The operating margin, excluding other income, stood at -4.58%, which is an improvement from -7.58% in Q3 FY26, yet it remains in negative territory, indicating ongoing operational difficulties. The persistent negative margins raise concerns about the company's ability to generate sustainable profits from its core business activities. CHD Chemicals has faced significant challenges over the past five years, with a cumulative decline in revenue of 40.81% and ongoing net losses throughout FY26. The company's financial metrics, including a return on equity of -2.06% and a return on capital employed of -0.88%, highlight a troubling trend of value destruction for shareholders. Additionally, the company's high debt-to-EBITDA ratio of 8.11 times and weak interest coverage ratio of 0.21 times indicate financial stress, further complicating its operational landscape. In light of these results, CHD Chemicals has seen an adjustment in its evaluation, reflecting the ongoing struggles within the company. The absence of institutional interest and the company's micro-cap status contribute to a challenging investment environment, characterized by low liquidity and high volatility. Overall, while there are signs of sequential revenue growth, the underlying operational weaknesses and persistent losses suggest that the company faces significant hurdles in restoring investor confidence and achieving sustainable profitability.